These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 25733327

  • 1. Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.
    Shen L, Peng H, Peng R, Fan Q, Zhao S, Xu D, Morisseau C, Chiamvimonvat N, Hammock BD.
    Atherosclerosis; 2015 Apr; 239(2):557-65. PubMed ID: 25733327
    [Abstract] [Full Text] [Related]

  • 2. A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro.
    Shen L, Peng H, Zhao S, Xu D.
    Biol Chem; 2014 Apr; 395(4):443-51. PubMed ID: 24225128
    [Abstract] [Full Text] [Related]

  • 3. The phosphatase activity of soluble epoxide hydrolase regulates ATP-binding cassette transporter-A1-dependent cholesterol efflux.
    Lien CC, Chen CH, Lee YM, Guo BC, Cheng LC, Pan CC, Shyue SK, Lee TS.
    J Cell Mol Med; 2019 Oct; 23(10):6611-6621. PubMed ID: 31436906
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
    Roche C, Besnier M, Cassel R, Harouki N, Coquerel D, Guerrot D, Nicol L, Loizon E, Remy-Jouet I, Morisseau C, Mulder P, Ouvrard-Pascaud A, Madec AM, Richard V, Bellien J.
    Am J Physiol Heart Circ Physiol; 2015 May 01; 308(9):H1020-9. PubMed ID: 25724490
    [Abstract] [Full Text] [Related]

  • 7. [Soluble epoxide hydrolase inhibitor t-AUCB ameliorates ox-LDL induced conversion of macrophages into foam cells through activating the PPARγ-ABCA1 pathway].
    Zhao TT, Peng R, Shen L, Zhao X, Xu DY, Zhao SP.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar 01; 40(3):248-52. PubMed ID: 22801272
    [Abstract] [Full Text] [Related]

  • 8. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.
    Xu DY, Davis BB, Wang ZH, Zhao SP, Wasti B, Liu ZL, Li N, Morisseau C, Chiamvimonvat N, Hammock BD.
    Int J Cardiol; 2013 Aug 20; 167(4):1298-304. PubMed ID: 22525341
    [Abstract] [Full Text] [Related]

  • 9. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA, Faulkner J, Pye C, Rouch K, Alhashim A, Maddipati KR, Baban B.
    Clin Sci (Lond); 2013 Oct 20; 125(7):349-59. PubMed ID: 23611540
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S, Baumer Y, Toulmin E, Seng K, Boisvert WA.
    Arterioscler Thromb Vasc Biol; 2015 Feb 20; 35(2):323-31. PubMed ID: 25524771
    [Abstract] [Full Text] [Related]

  • 11. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS, Murphy AJ, Abramowicz S, Ntonga V, Welch CL, Tall AR, Westerterp M.
    Arterioscler Thromb Vasc Biol; 2014 Feb 20; 34(2):279-84. PubMed ID: 24311381
    [Abstract] [Full Text] [Related]

  • 12. microRNAs in lipoprotein metabolism and cardiometabolic disorders.
    Rotllan N, Price N, Pati P, Goedeke L, Fernández-Hernando C.
    Atherosclerosis; 2016 Mar 20; 246():352-60. PubMed ID: 26828754
    [Abstract] [Full Text] [Related]

  • 13. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
    Yakushiji E, Ayaori M, Nishida T, Shiotani K, Takiguchi S, Nakaya K, Uto-Kondo H, Ogura M, Sasaki M, Yogo M, Komatsu T, Lu R, Yokoyama S, Ikewaki K.
    Arterioscler Thromb Vasc Biol; 2016 Apr 20; 36(4):591-7. PubMed ID: 26848156
    [Abstract] [Full Text] [Related]

  • 14. Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein.
    Lv Y, Yang J, Gao A, Sun S, Zheng X, Chen X, Wan W, Tang C, Xie W, Li S, Guo D, Peng T, Zhao G, Zhong L.
    Acta Biochim Biophys Sin (Shanghai); 2019 May 23; 51(5):471-483. PubMed ID: 30950489
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.
    Huang L, Fan B, Ma A, Shaul PW, Zhu H.
    J Lipid Res; 2015 May 23; 56(5):986-97. PubMed ID: 25761370
    [Abstract] [Full Text] [Related]

  • 16. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.
    Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, Fernandez-Hernando C, Fisher EA, Moore KJ.
    J Clin Invest; 2011 Jul 23; 121(7):2921-31. PubMed ID: 21646721
    [Abstract] [Full Text] [Related]

  • 17. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
    Zhang W, Yang AL, Liao J, Li H, Dong H, Chung YT, Bai H, Matkowskyj KA, Hammock BD, Yang GY.
    Dig Dis Sci; 2012 Oct 23; 57(10):2580-91. PubMed ID: 22588244
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
    Chaudhary KR, Abukhashim M, Hwang SH, Hammock BD, Seubert JM.
    J Cardiovasc Pharmacol; 2010 Jan 23; 55(1):67-73. PubMed ID: 19834332
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport.
    Yamamoto S, Tanigawa H, Li X, Komaru Y, Billheimer JT, Rader DJ.
    Circulation; 2011 Sep 20; 124(12):1382-90. PubMed ID: 21859969
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.
    Li D, Liu Y, Zhang X, Lv H, Pang W, Sun X, Gan LM, Hammock BD, Ai D, Zhu Y.
    J Mol Cell Cardiol; 2016 Sep 20; 98():128-37. PubMed ID: 27496380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.